Your browser doesn't support javascript.
loading
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLC.
Carbone, Federico; Ministrini, Stefano; Bonaventura, Aldo; Vecchié, Alessandra; Minetti, Silvia; Bardi, Nicholas; Elia, Edoardo; Ansaldo, Anna Maria; Ferrara, Daniele; Rijavec, Erika; Dal Bello, Maria Giovanna; Biello, Federico; Rossi, Giovanni; Tagliamento, Marco; Alama, Angela; Coco, Simona; Spallarossa, Paolo; Grossi, Francesco; Genova, Carlo; Montecucco, Fabrizio.
Afiliação
  • Carbone F; First Clinic of internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Ministrini S; IRCCS Ospedale Policlinico San Martino, Genoa - Italian Cardiovascular Network, Genoa, Italy.
  • Bonaventura A; Center for Molecular Cardiology, Universität Zürich, Schlieren, Switzerland.
  • Vecchié A; Internal Medicine, Angiology and Atherosclerosis, Department of Medicine and Surgery, Università degli Studi di Perugia, Perugia, Italy.
  • Minetti S; First Clinic of internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Bardi N; Division of Cardiology, Department of Internal Medicine, Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Elia E; First Clinic of internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Ansaldo AM; Division of Cardiology, Department of Internal Medicine, Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Ferrara D; First Clinic of internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Rijavec E; First Clinic of internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Dal Bello MG; Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Turin, Italy.
  • Biello F; First Clinic of internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Rossi G; First Clinic of internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Tagliamento M; Medical Oncology Unit, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Alama A; UOS Tumori Polmonari, IRCCS Ospedale Policlinico San Martino Genoa, Genoa, Italy.
  • Coco S; Department of Internal Medicine and Medical Specialties (DiMI), University of Genova, Genoa, Italy.
  • Spallarossa P; UOS Tumori Polmonari, IRCCS Ospedale Policlinico San Martino Genoa, Genoa, Italy.
  • Grossi F; UOS Tumori Polmonari, IRCCS Ospedale Policlinico San Martino Genoa, Genoa, Italy.
  • Genova C; Department of Internal Medicine and Medical Specialties (DiMI), University of Genova, Genoa, Italy.
  • Montecucco F; UOS Tumori Polmonari, IRCCS Ospedale Policlinico San Martino Genoa, Genoa, Italy.
Eur J Clin Invest ; 52(1): e13668, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34390488
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article